AirPhysio
AirPhysio is an Australian medical hardware company founded in 2016 that sells handheld Oscillating Positive Expiratory Pressure (OPEP) devices for mucus clearance and lung expansion, serving individuals with asthma, COPD, cystic fibrosis, athletes, and pediatric/elderly users via direct-to-consumer e-commerce and global distribution partners.
- Company typePrivate
- Founded2016
- HeadquartersTweed Heads, Australia
- Headcount1–10
- GTM typeB2C
- OfferingHardware or Manufacturing
What AirPhysio does
AirPhysio Pty Ltd (operating through parent Better Breathing Devices Pty Ltd) is an Australian medical hardware company founded in 2016 that designs, manufactures, and sells Oscillating Positive Expiratory Pressure (OPEP) devices for mucus clearance and lung expansion. The core technology centers on a handheld device containing a stainless steel ball that, when the user exhales through the mouthpiece, oscillates to vibrate airway walls, increase endobronchial pressure, and mobilize mucus for natural clearance. The product line is segmented by user profile: the Average Lung Capacity device (USD$66.99) targets general adults with mild respiratory conditions, the Low Lung Capacity variant (USD$73.99) serves children, the elderly, and severe-condition patients via smaller ball resistance, and the Better Breathing Sport (USD$73.99) targets athletes and physically active users. Accessories include replacement ball bearings, travel cases, and bundled packs such as the BioHack Your Sleep Pack (AirPhysio device combined with Reishi Mushroom Extract, USD$82.57).
The company generates revenue primarily through direct-to-consumer e-commerce on airphysio.com, complemented by regional distribution partners in the USA, Middle East, South East Asia, UK, Europe, and Australia; a QVC television shopping partnership for the US market; and institutional access via NDIS (National Disability Insurance Scheme) registration and Bupa insurance coverage support in Australia. Pricing tiers range from USD$9.99 replacement ball bearings up to USD$133.98 for a three-device bundle. Clinical credibility is anchored by Griffith University validation studies comparing the device against the incumbent Flutter OPEP device. AirPhysio is TGA-registered, internationally trademarked, and has accumulated multiple awards including the Yiwu International Best Product award (2017), Optus MyBusiness Start-Up Business of the Year (2017), and regional exporter recognition (2021). The company operates with 1-10 employees and is led by founder and Managing Director Paul O'Brien.
The customer base targets four overlapping segments: individuals diagnosed with asthma, COPD, cystic fibrosis, bronchiectasis, and chronic bronchitis; athletes and physically active users seeking lung capacity gains; elderly users and smokers experiencing natural lung function decline; and children with pediatric respiratory conditions. Marketing is primarily product-led and educational, leveraging content marketing (respiratory health blog), social media (Facebook, Instagram, YouTube, LinkedIn), video testimonials, earned media including Modern Living with Kathy Ireland (aired January 2018) and 7 News Gold Coast, and a 30-day satisfaction guarantee to reduce purchase friction. Revenue figures are not publicly disclosed.
AirPhysio firmographics
Firmographics- Name
- AirPhysio
- Legal name
- AirPhysio Pty Ltd
- Website
- https://airphysio.com
- Company type
- Private
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- AirPhysio is an Australian medical hardware company founded in 2016 that sells handheld Oscillating Positive Expiratory Pressure (OPEP) devices for mucus clearance and lung expansion, serving individuals with asthma, COPD, cystic fibrosis, athletes, and pediatric/elderly users via direct-to-consumer e-commerce and global distribution partners.
- Ownership category
- akta.pro rank
AirPhysio industry classification
Industry- Product category
- Respiratory medical devices
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Chest Physiotherapy & Airway Clearance Devices (PEP, Oscillatory PEP, HFCWO, Cough Assist) (HLAHAGAJ)
- akta.pro secondary industries
- Respiratory & Sleep Therapy Equipment (Oxygen, CPAP/BiPAP, Nebulizers) (HSABAKAD), Home Ventilation, Oxygen Therapy & Respiratory DME Clinical Management (HLAKANAM), Asthma & Airway Disease Specialty Care (HLAKAAAC)
Keywords
Where AirPhysio is headquartered
LocationHeadquarters
- HQ city
- Tweed Heads
- HQ country
- Australia
- HQ region
- Oceania
Offices5 records
Markets served
AirPhysio business model
Business model- GTM type
- B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Marketing or Sales, Operations, Personnel, Technology or R&D
Revenue model
- OPEP Device Sales: Primary revenue from selling handheld OPEP devices directly to consumers. Products are available in multiple variants for different lung capacities (Low, Average, Sports) and target audiences (Kids, Adults). Bundle deals such as Buy 2 Get 1 Free packages drive higher transaction values.
- Accessories and Replacement Parts: Revenue from selling replacement ball bearings, travel cases, and bundled packages including the BioHack Your Sleep Pack which combines the device with Reishi mushroom extract.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | AirPhysio Average Lung Capacity Device - Standard consumer version |
| Unit Pricing | Pay-as-you-go | AirPhysio Low Lung Capacity Device - For reduced lung function users |
| Unit Pricing | Pay-as-you-go | Better Breathing Sport Device |
| Unit Pricing | Pay-as-you-go | Better Breathing Kids Device |
| Unit Pricing | Pay-as-you-go | Buy 2 Get 1 Free Bundle - Average Lung Devices |
| Unit Pricing | Pay-as-you-go | Travel Case Package |
| Unit Pricing | Pay-as-you-go | Ball Bearing Replacement - Sports, Average, Low Lung |
| Unit Pricing | Pay-as-you-go | QVC Package - Travel Case and Device |
| Unit Pricing | Pay-as-you-go | BioHack Your Sleep Pack |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels6 records
AirPhysio product offering
Product offeringCore offering
AirPhysio designs, manufactures, and sells handheld Oscillating Positive Expiratory Pressure (OPEP) devices that use an all-natural process with a stainless steel ball to create airway vibrations and positive expiratory pressure for mucus clearance and lung expansion. The company offers variant devices for different lung capacities (Low, Average) and audiences (Kids, Sport/Adults), along with replacement ball bearings, travel cases, and bundled packages. Products are sold direct-to-consumer globally for use in the treatment and prevention of asthma, COPD, cystic fibrosis, bronchiectasis, atelectasis, and other respiratory conditions.
Product overview
AirPhysio is a mucus clearance and lung expansion device company offering Oscillating Positive Expiratory Pressure (OPEP) devices. The product line centers on the AirPhysio OPEP device family with three main variants: Average Lung Capacity (medium resistance for general use), Low Lung Capacity (low resistance for children/elderly/severe conditions), and Better Breathing Sport (for athletes). The portfolio also includes Better Breathing Kids for pediatric use, plus accessories like Ball Bearing Replacements and Travel Cases. The company also offers bundled products such as the BioHack Your Sleep Pack combining the device with Reishi Mushroom Extract, and multi-device value packs. All devices use a stainless steel ball mechanism to create oscillations that vibrate airways, mobilize mucus, and increase expiratory airflow for natural, drug-free respiratory therapy.
Differentiator
Problem solved
Functional benefit
Brands
- Better Breathing Sport: A sports-oriented OPEP device variant designed for athletes and physically active individuals to increase lung capacity, reduce breathlessness during exercise, and speed up post-workout recovery.
- Better Breathing Kids
- BioHack Your Sleep Pack
Products and services
- AirPhysio Average Lung Capacity Device Oscillating Positive Expiratory Pressure (OPEP) mucus clearance and lung expansion device designed for most teenagers and adults with medium resistance setting; intended for individuals with mild respiratory conditions or reasonable fitness levels.
- AirPhysio Low Lung Capacity Device OPEP device with small steel ball providing less expiratory resistance, designed for children, adults with low lung capacity, severe respiratory conditions, or weak respiratory muscles such as elderly and spinal cord injury patients.
- Better Breathing Sport OPEP device designed for athletes and physically active individuals to increase lung capacity, reduce breathlessness during exercise, increase exercise tolerance, and speed up recovery times after working out or training.
- Better Breathing Kids Child-friendly OPEP device variant designed for children's respiratory needs with appropriate resistance levels for smaller lungs.
- Ball Bearing Replacement Replacement stainless steel ball bearings available in Sports, Average, and Low Lung sizes for AirPhysio OPEP devices, allowing individualized treatment according to age and tolerance.
- AirPhysio Travel Case Protective travel case with sunglass sleeve for transporting AirPhysio devices, designed for users who need to use the device while traveling.
- QVC Package Package including AirPhysio device and travel case, sold through QVC retail channel.
- BioHack Your Sleep Pack Bundle product combining AirPhysio Average Resistance Device with 4oz Reishi Mushroom Extract to support respiratory health and relaxation for deep, restorative sleep.
Quantifiable outcome
- Lung capacity reduction of 5-25 ml/year for asthmatics and 33 ml/year for smokers may be slowed with regular device use
- +2 more outcomes
Companies that use AirPhysio
Customer profileNamed customers4 records
Segments4 records
Ideal customer profiles3 records
AirPhysio technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
AirPhysio partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core and minor.
- Griffith UniversitycoreGriffith University conducted scientific validation studies comparing AirPhysio OPEP device against the Flutter device. Professor Norman Morris from the School of Allied Health Science and Menzies Health Institute Griffith University prepared validation reports confirming the device's effectiveness for mucus clearance and lung expansion.
- NDIS (National Disability Insurance Scheme)coreAirPhysio is a registered NDIS provider, enabling eligible Australians with permanent and significant disabilities to access the device through their NDIS plans for respiratory support.
- BupaminorBupa health insurance coverage support for eligible customers. Device is recognized by Bupa for potential coverage under applicable health insurance plans.
- QVCminorQVC television shopping channel partnership for product distribution in the USA market. QVC Package available for purchase through the television shopping platform.
- Regional Distribution PartnerscoreDistribution partners operating across USA, Middle East, South East Asia, UK and Europe, and Australia. These partners enable international reach and local fulfillment for customers outside direct shipping areas.
Scale indicators3 records
Recent moves6 records
Expansion highlights5 records
AirPhysio competitors and assessment
Company assessmentDirect peers
- Monaghan Medical (Trudell Medical): Monaghan/Trudell manufactures the Aerobika OPEP device, a direct oscillating positive expiratory pressure competitor to AirPhysio targeting the same mucus clearance use case in patients with COPD, bronchiectasis, and cystic fibrosis. Both companies sell handheld, drug-free OPEP devices into the same clinical and consumer channels.
- Vyaire Medical: Vyaire Medical sells the Acapella OPEP device, a direct competitor to AirPhysio in the oscillating positive expiratory pressure category used for airway clearance and lung expansion. Vyaire brings a much larger commercial footprint across hospitals and DME channels.
- PARI Medical Holding: PARI manufactures the PARI O-PEP, a direct oscillating positive expiratory pressure competitor to AirPhysio. PARI is well-established in respiratory drug delivery and airway clearance, with a global clinical sales force and similar end customers to AirPhysio.
Emerging players
- Electromed: Electromed makes the SmartVest airway clearance system, a high-frequency chest wall oscillation (HFCWO) device used for the same mucus clearance indication AirPhysio addresses. Both companies target bronchiectasis, COPD, and cystic fibrosis patients, though Electromed's solution is a wearable vest versus AirPhysio's handheld OPEP.
- International Biophysics (AffloVest): International Biophysics manufactures the AffloVest, a portable HFCWO airway clearance device that competes for the same bronchiectasis, COPD, and cystic fibrosis patients as AirPhysio. AffloVest represents a higher-end, prescription-driven alternative to AirPhysio's consumer-grade OPEP.
Broad incumbents
- RespirTech (Philips): RespirTech, part of Philips, provides the inCourage airway clearance system, an adjacent therapy to AirPhysio's OPEP for patients with chronic respiratory conditions. Both companies compete for the same mucus clearance prescription and reimbursement pathways, though RespirTech uses a different mechanism (HFCWO).
- ResMed: ResMed is a global leader in respiratory and sleep-disordered breathing devices (CPAP, BiPAP, ventilators) and operates in the broader airway health category that AirPhysio addresses. While ResMed's core products are sleep/ventilation rather than OPEP, both companies serve patients with chronic respiratory conditions and sell through overlapping DME and clinician channels.
- Philips Respironics: Philips Respironics is a large incumbent in respiratory care (CPAP, BiPAP, oxygen, ventilators) with overlapping end patients and DME/pharmacy channels to AirPhysio. While Philips's core portfolio is different, it competes indirectly for the same chronic respiratory patient wallet.
- Drive DeVilbiss Healthcare: Drive DeVilbiss is a broad-line durable medical equipment manufacturer selling nebulizers, oxygen concentrators, and airway clearance accessories into the same home-respiratory market as AirPhysio. Both compete for shelf space at DME distributors and online health retailers.
Regional players
- Aero Healthcare: Aero Healthcare is an Australia-based medical device and first-aid manufacturer with overlapping respiratory and DME product lines. As a fellow Australian health brand, it provides a useful regional comparable for AirPhysio's home-market positioning and international export footprint.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
AirPhysio social profiles
Digital presenceAirPhysio financial estimates
Financial estimateRevenue estimate
Valuation estimate
AirPhysio leadership team
Management profileNumber of profiles
Profiles1 record
AirPhysio funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
AirPhysio M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about AirPhysio
What does AirPhysio do?
AirPhysio designs, manufactures, and sells handheld Oscillating Positive Expiratory Pressure (OPEP) devices that use an all-natural process with a stainless steel ball to create airway vibrations and positive expiratory pressure for mucus clearance and lung expansion. The company offers variant devices for different lung capacities (Low, Average) and audiences (Kids, Sport/Adults), along with replacement ball bearings, travel cases, and bundled packages. Products are sold direct-to-consumer globally for use in the treatment and prevention of asthma, COPD, cystic fibrosis, bronchiectasis, atelectasis, and other respiratory conditions.
Is AirPhysio a public or private company?
AirPhysio is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was AirPhysio founded?
AirPhysio was founded in 2016. It employs 1 to 10 people.
Where is AirPhysio based?
AirPhysio is headquartered in Tweed Heads, Australia, in the Oceania region.
How does AirPhysio make money?
Two revenue lines are on record. OPEP Device Sales are the primary driver. The others are accessories and Replacement Parts.
Who are AirPhysio's main competitors?
Direct peers on record are Monaghan Medical (Trudell Medical), Vyaire Medical and PARI Medical Holding. Emerging players are Electromed and International Biophysics (AffloVest). Broad incumbents are RespirTech (Philips), ResMed, Philips Respironics and Drive DeVilbiss Healthcare. Aero Healthcare is listed as a regional player.
Does AirPhysio have an API?
No public API is recorded for AirPhysio.
What industry is AirPhysio in?
AirPhysio's product category is Respiratory medical devices. Its primary akta.pro industry code is HLAHAGAJ, Chest Physiotherapy & Airway Clearance Devices (PEP, Oscillatory PEP, HFCWO, Cough Assist), with a secondary code of HSABAKAD, Respiratory & Sleep Therapy Equipment (Oxygen, CPAP/BiPAP, Nebulizers). Its NAICS code is 334510 and its SIC code is 3841.